66 related articles for article (PubMed ID: 8328316)
1. Development and characterization of a polyclonal antiserum-based radioimmunoassay for dog osteocalcin.
Fanti P; Colombo G; Yao C; Brown SA; Vernon MW; Malluche HH
J Bone Miner Res; 1993 Jun; 8(6):745-52. PubMed ID: 8328316
[TBL] [Abstract][Full Text] [Related]
2. Development of a heterologous radioimmunoassay for canine osteocalcin.
Wang SP; Demarest KT; Gunnet JW; Baylink DJ; Lau KH
Calcif Tissue Int; 1994 Aug; 55(2):134-40. PubMed ID: 7953979
[TBL] [Abstract][Full Text] [Related]
3. Development and application of a serum C-telopeptide and osteocalcin assay to measure bone turnover in an ovariectomized rat model.
Srivastava AK; Bhattacharyya S; Castillo G; Wergedal J; Mohan S; Baylink DJ
Calcif Tissue Int; 2000 Jun; 66(6):435-42. PubMed ID: 10821880
[TBL] [Abstract][Full Text] [Related]
4. Influence of type and breed of horse on serum osteocalcin concentration, and evaluation of the applicability of a bovine radioimmunoassay and a human immunoradiometric assay [corrected].
Lepage OM; Eicher R; Uebelhart B; Tschudi P
Am J Vet Res; 1997 Jun; 58(6):574-8. PubMed ID: 9185960
[TBL] [Abstract][Full Text] [Related]
5. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay.
Garnero P; Grimaux M; Demiaux B; Preaudat C; Seguin P; Delmas PD
J Bone Miner Res; 1992 Dec; 7(12):1389-98. PubMed ID: 1481725
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of modal damping factor as a diagnostic tool for osteoporosis and its relation with serum osteocalcin and collagen I N-telopeptide for monitoring the efficacy of alendronate in ovariectomized rats.
Christopoulou GE; Stavropoulou A; Anastassopoulos G; Panteliou SD; Papadaki E; Karamanos NK; Panagiotopoulos E
J Pharm Biomed Anal; 2006 Jun; 41(3):891-7. PubMed ID: 16488571
[TBL] [Abstract][Full Text] [Related]
7. Epitope mapping of nine monoclonal antibodies against osteocalcin: combinations into two-site assays affect both assay specificity and sample stability.
Hellman J; Käkönen SM; Matikainen MT; Karp M; Lövgren T; Väänänen HK; Pettersson K
J Bone Miner Res; 1996 Aug; 11(8):1165-75. PubMed ID: 8854253
[TBL] [Abstract][Full Text] [Related]
8. [Serum osteocalcin in children with chronic renal insufficiency].
Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
[TBL] [Abstract][Full Text] [Related]
9. A heterologous radioimmunoassay system for human osteocalcin. Applications in performance sports girls.
Simionescu L; Dumitru C; Zamfir-Grigorescu D; Dimitriu V; Câmpean G; Georgescu E; Stroescu V; Iosif C
Endocrinologie; 1987; 25(2):101-6. PubMed ID: 3498205
[TBL] [Abstract][Full Text] [Related]
10. Development of a synthetic peptide-based tartrate-resistant acid phosphatase radioimmunoassay for the measurement of bone resorption in rat serum.
Srivastava AK; Libanati C; Lane N; Baylink DJ
J Bone Miner Metab; 2002; 20(2):66-72. PubMed ID: 11862527
[TBL] [Abstract][Full Text] [Related]
11. Multiple osteocalcin fragments in human urine and serum as detected by a midmolecule osteocalcin radioimmunoassay.
Taylor AK; Linkhart S; Mohan S; Christenson RA; Singer FR; Baylink DJ
J Clin Endocrinol Metab; 1990 Feb; 70(2):467-72. PubMed ID: 2298858
[TBL] [Abstract][Full Text] [Related]
12. Secretion of osteocalcin and its propeptide from human osteoblastic cells: dissociation of the secretory patterns of osteocalcin and its propeptide.
Hosoda K; Kanzaki S; Eguchi H; Kiyoki M; Yamaji T; Koshihara Y; Shiraki M; Seino Y
J Bone Miner Res; 1993 May; 8(5):553-65. PubMed ID: 8511982
[TBL] [Abstract][Full Text] [Related]
13. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro.
Garnero P; Grimaux M; Seguin P; Delmas PD
J Bone Miner Res; 1994 Feb; 9(2):255-64. PubMed ID: 8140939
[TBL] [Abstract][Full Text] [Related]
14. Development and application of a synthetic peptide-based osteocalcin assay for the measurement of bone formation in mouse serum.
Srivastava AK; Castillo G; Wergedal JE; Mohan S; Baylink DJ
Calcif Tissue Int; 2000 Sep; 67(3):255-9. PubMed ID: 10954781
[TBL] [Abstract][Full Text] [Related]
15. The serum osteocalcin levels in adult and aged hypothyroid patients.
Simionescu L; Dumitriu L; Dimitriu V; Zamfir-Grigorescu D; Dumitriu E; Câmpean G; Ionescu T; Purice M
Endocrinologie; 1988; 26(4):255-60. PubMed ID: 3264931
[TBL] [Abstract][Full Text] [Related]
16. Characterization of aged osteocalcin fragments derived from bone resorption.
Cloos PA; Christgau S
Clin Lab; 2004; 50(9-10):585-98. PubMed ID: 15481635
[TBL] [Abstract][Full Text] [Related]
17. Effects of sample collection and handling on concentration of osteocalcin in equine serum.
Hope E; Johnston SD; Hegstad RL; Geor RJ; Murphy MJ
Am J Vet Res; 1993 Jul; 54(7):1017-20. PubMed ID: 8368594
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of two proximal elements in the rat osteocalcin gene promoter that may confer species-specific regulation.
Heinrichs AA; Banerjee C; Bortell R; Owen TA; Stein JL; Stein GS; Lian JB
J Cell Biochem; 1993 Nov; 53(3):240-50. PubMed ID: 8263041
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a specific radioimmunoassay for equine osteocalcin.
Carstanjen B; Sulon J; Banga-Mboko H; Beckers JF; Remy B
Domest Anim Endocrinol; 2003 Jan; 24(1):31-41. PubMed ID: 12450623
[TBL] [Abstract][Full Text] [Related]
20. Measurement of serum bone gla-protein (BGP) in humans with an ovine BGP-based radioimmunoassay.
Pastoureau P; Delmas PD
Clin Chem; 1990 Sep; 36(9):1620-4. PubMed ID: 2208702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
